Clinical management of cardiovascular disease in HIV-infected patients

Human immunodeficiency virus (HIV) is no longer a deadly disease, but is now a chronic condition since the introduction of antiretroviral therapy (ART) [1]. Cardiovascular disease (CVD), specifically coronary artery disease, is becoming a significant health burden in HIV-infected (HIV+) patients. Our current understanding of the mechanisms underlying HIV-associated CVD is largely obtained from clinical observations [1]. ART treatment suppresses, but does not eradicate HIV. Extensive clinical evidence indicates that well-controlled HIV infection with or without ART (eg.

Source: Trends in Cardiovascular Medicine - July 21, 2017 Category: Cardiology Authors: Alison Kearns, Tricia H. Burdo, Xuebin Qin Source Type: research